Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

An Exceptional Case of Atrial Fibrillation Arrhythmia Induced by Etoposide

Author(s): Wala Ben Kridis, Afef Khanfir, Faten Triki and Mounir Frikha

Volume 8, Issue 4, 2013

Page: [287 - 289] Pages: 3

DOI: 10.2174/15748863113080990047

Price: $65

Abstract

Background: Arrhythmia induced by etoposide is exceedingly rare. There are only a very few individual case histories of arrhythmias during etoposide infusion, including atrial fibrillation. Objective: Through this uncommon case, we propose to study the pathophysiology, the diagnosis and the management of this entity.

Case Report: We report a case of a 57-year-old man, without cardiac history, followed for endocrine tumor of the pancreas with liver metastases who had presented atrial fibrillation (AF) after etoposide infusion.

Conclusion: It is important to consider cardiac monitoring during etoposide infusion in patients with known cardiac disease or at high risk of cardiac complications.

Keywords: Atrial fibrillation, cardiotoxicity, chemotherapy, diagnosis, etoposide, prognosis.

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy